Capozide BDBM21642 Lopirin (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid Captopril CHEMBL1560 SQ 14,225 SQ14534 US11491146, Compound L-Captopril
CHEMBL434965 (R)-1-((S)-3-Mercapto-2-methyl-propionyl)-pyrrolidine-2-carboxylic acid BDBM50140754 D-CAPTOPRIL
(L)-1-(3-Mercapto-propionyl)-pyrrolidine-2-carboxylic acid 1-(3-Mercapto-propionyl)-pyrrolidine-2-carboxylic acid(Captopril analogue) 1-(3-Mercapto-propionyl)-pyrrolidine-2-carboxylic acid CHEMBL10962 BDBM50018792 (S)-1-(3-mercaptopropanoyl)pyrrolidine-2-carboxylic acid
- Ojima, I; Jameison, FA A new potent inhibitor for angiotensin converting enzyme: (R,S)-captopril-F3 Bioorg Med Chem Lett 1: 581-584 (1991)
- Hanessian, S; Reinhold, U; Saulnier, M; Claridge, S Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity. Bioorg Med Chem Lett 8: 2123-8 (1999)
- Tzakos, AG; Naqvi, N; Comporozos, K; Pierattelli, R; Theodorou, V; Husain, A; Gerothanassis, IP The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme. Bioorg Med Chem Lett 16: 5084-7 (2006)